L’Agence européenne du médicament (EMA) vient de repêcher un nouveau médicament anti-Alzheimer, le lécanémab (Leqembi), dont ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback